Axxam, a privately-owned innovative Partner Research Organization (iPRO) with a strong and leading expertise for the identification and characterization of bioactive compounds, announced this month the opening of its first Scandinavian office, located in the Copenhagen Bioscience Park (COBIS) in Copenhagen, Denmark.
“Copenhagen was the right choice for our first office in the Nordic countries” said Dr. Stefan Lohmer, co-founder and CEO of Axxam. "Copenhagen is evolving as a biotechnology center and we want to be able to work face-to-face with our clients and partners, sharing expertise. Our new facility at COBIS will bring us closer to the important Nordic life science, pharma and biotech environment, and I believe that this region will fit extremely well with our iPRO approach. Many early stage companies would benefit from our expertise to identify bioactive compounds for their innovative targets using our HTS/HCS platforms and compound collections. Through our local presence we want to increase the important direct interaction with start-up companies, VCs and pharma/biotech companies.”
Katherina Orellana, Business Development Manager, will be managing this office.
For more information: http://axxam.com/